FDA Inspection 1047419 — United Exchange Corp.
The FDA completed an inspection of United Exchange Corp. on April 6, 2018 in Rialto, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 6, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rialto, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1418 | 21 CFR 211.42(c)(7) | Quarantined Drug Products Area |
| 4351 | 21 CFR 211.160(b)(3) | Drug products - samples representative, identified properly |